Analyst Group: Analyst Group Interview Nykode Therapeutics' CEO Michael Engsig
27 augusti, 14:54
27 augusti, 14:54
We have interviewed Michael Engsig, CEO of Nykode Therapeutics. In the interview Michael tell us where the company is today, the strategy going forward and why the company is a good investment.
About Analyst Group: One of the Nordics fastest growing equity research boutiques with a focus on small and medium-sized listed companies.
Read more about Analyst Group (Swedish)
This is a press release from Analyst Group regarding the publication of an interview with Nykode Therapeutics.
27 augusti, 14:54
We have interviewed Michael Engsig, CEO of Nykode Therapeutics. In the interview Michael tell us where the company is today, the strategy going forward and why the company is a good investment.
About Analyst Group: One of the Nordics fastest growing equity research boutiques with a focus on small and medium-sized listed companies.
Read more about Analyst Group (Swedish)
This is a press release from Analyst Group regarding the publication of an interview with Nykode Therapeutics.
Rapporter
Regeringsbygget
Aktieanalys
Rapporter
Regeringsbygget
Aktieanalys
1 DAG %
Senast
OMX Stockholm 30
−0,62%
(vid stängning)
OMX Stockholm 30
1 DAG %
Senast
3 256,08